Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Tech Weekly: CES Announcements Reignite Memory Shortage Concerns January 11, 2026 Top 9 Global Lithium Stocks (Updated January 2026) January 10, 2026 Providence Gold Mines Inc. La Dama de Oro Gold & Financing Update January 10, 2026